ANTM - Anthem EPS beats by $0.69 beats on revenue

Anthem (ANTM): Q2 Non-GAAP EPS of $7.03 beats by $0.69; GAAP EPS of $7.25 beats by $1.22.Revenue of $33.3B (+14.1% Y/Y) beats by $80M.Medical membership of 44.3M vs. 43.8M consensus.Benefit expense ratio of 86.8% vs. 87.7% consensus.FY 2021 Guidance:GAAP net income is now expected to be greater than $24.89 per share, including approximately $0.61 per share of net unfavorable items. Excluding these items, adjusted net income is expected to be greater than $25.50* per share ($25.24 consensus).Medical membership is now expected to be in the range of 44.8 - 45.3 million. Risk-based membership is now expected to be in the range of 19.3 - 19.6 million. Fee-based membership is expected to be in the range of 25.5 - 25.7 million.Operating revenue is now expected to be approximately $137.1 billion vs. prior guidance of $135.1B, ($135.21B consensus), including premium revenue of $116.5 billion - $117.5 billion.Operating cash flow is now expected

For further details see:

Anthem EPS beats by $0.69, beats on revenue